Repurchase of own shares

In accordance with the mandate granted by the Annual General Meeting on June 5th 2008, the board of directors of ContextVision has decided to repurchase own shares. The repurchase program is planned to amount to 200,000 shares at a share price not lower than 20 NOK and not higher than 35 NOK. Repurchases will continue up until the next Annual General Meeting in June 2009, or until 200,000 shares have been repurchased.

The reason for the repurchase is to create shareholder value by decreasing the amount of outstanding shares.

SEB Enskilda in Oslo is managing the repurchase of shares.

For inquires please contact

Henrik Bergentoft
Chief Financial Officer
henrik.bergentoft@contextvision.se
+46 (0)8 750 35 52

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit www.contextvision.com.

Subscribe